StockpollyBeta
Get App
Popularity #2,228
CLPT · NASDAQ · Medical - Devices

ClearPoint Neuro (CLPT)

Enables neurosurgery, laser therapy, CNS delivery, and neurocritical care with navigation tools.

$15.75
After-hours close−0.04 (−0.25%)
At close$15.79(+13.03%)

In millions of USD, except per-share figures

In millionsQ3 FY23Sep 2023Q4 FY23Dec 2023Q1 FY24Mar 2024Q2 FY24Jun 2024Q3 FY24Sep 2024Q4 FY24Dec 2024Q1 FY25Mar 2025Q2 FY25Jun 2025Q3 FY25Sep 2025Q4 FY25Dec 2025Q1 FY26Mar 2026Q2 FY26Jun 2026
Revenue678888899101211
Cost of revenue233333343454
Gross profit345555566687
899101010111111131617
Research & development233333343355
666777877111212
Selling & marketing333444444577
General & administrative333333433656
Other expenses000000000000
Operating income−5−5−4−5−5−6−6−6−5−7−8−10
00000000−1−1−1−1
Interest income000000000000
Interest expense000000001111
Other non-operating income000000000000
Income before tax−5−5−4−4−5−5−6−6−6−8−10−11
Income tax expense000000000000
Net income from continuing operations−5−5−4−4−5−5−6−6−6−8−10−11
Net income−5−5−4−4−5−5−6−6−6−8−10−11
EPS, basic−$0.20−$0.19−$0.16−$0.16−$0.18−$0.20−$0.22−$0.21−$0.21−$0.27−$0.32−$0.38
EPS, diluted−$0.20−$0.19−$0.16−$0.16−$0.18−$0.20−$0.22−$0.21−$0.21−$0.27−$0.32−$0.38
Weighted average shares, basic252525272827282828283030
Weighted average shares, diluted252525272827282828283030
EBITDA−4−4−4−4−4−5−6−5−5−6−7−9
Depreciation & amortization000000010111
EBIT−5−5−4−4−5−5−6−6−5−7−8−10